224 related articles for article (PubMed ID: 15190510)
1. Myelodysplastic syndromes: From pathogenesis and prognosis to treatment.
Fenaux P
Semin Hematol; 2004 Apr; 41(2 Suppl 4):6-12. PubMed ID: 15190510
[TBL] [Abstract][Full Text] [Related]
2. New agents in myelodysplastic syndromes.
Jabbour EJ; Giles FJ
Curr Hematol Rep; 2005 May; 4(3):191-9. PubMed ID: 15865871
[TBL] [Abstract][Full Text] [Related]
3. New approaches to the treatment of myelodysplasia.
List AF
Oncologist; 2002; 7 Suppl 1():39-49. PubMed ID: 11961208
[TBL] [Abstract][Full Text] [Related]
4. New agents in myelodysplastic syndromes.
Jabbour E; Giles FJ
Curr Hematol Malig Rep; 2006 Mar; 1(1):25-33. PubMed ID: 20425328
[TBL] [Abstract][Full Text] [Related]
5. [Recent advances in the treatment of myelodysplastic syndromes].
Gelsi-Boyer V; Vey N
Rev Med Interne; 2006 Aug; 27(8):600-9. PubMed ID: 16713027
[TBL] [Abstract][Full Text] [Related]
6. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
7. The genetic and molecular pathogenesis of myelodysplastic syndromes.
Shallis RM; Ahmad R; Zeidan AM
Eur J Haematol; 2018 Sep; 101(3):260-271. PubMed ID: 29742289
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndromes--an overview for the practitioner].
Solenthaler M; Tobler A
Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
[TBL] [Abstract][Full Text] [Related]
9. Novel therapies for myelodysplastic syndromes.
Faderl S; Kantarjian HM
Cancer; 2004 Jul; 101(2):226-41. PubMed ID: 15241818
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndromes.
Hofmann WK; Lübbert M; Hoelzer D; Phillip Koeffler H
Hematol J; 2004; 5(1):1-8. PubMed ID: 14745424
[TBL] [Abstract][Full Text] [Related]
11. Pediatric myelodysplastic syndromes.
Rytting ME
Curr Hematol Rep; 2004 May; 3(3):173-7. PubMed ID: 15087064
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndromes.
Scott BL; Deeg HJ
Annu Rev Med; 2010; 61():345-58. PubMed ID: 20059342
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndrome: An update on diagnosis and therapy.
Koppel A; Schiller G
Curr Hematol Malig Rep; 2009 Jan; 4(1):10-6. PubMed ID: 20425433
[TBL] [Abstract][Full Text] [Related]
14. Treating myelodysplastic syndromes.
Ryan C; McCann S
IDrugs; 2005 Apr; 8(4):320-6. PubMed ID: 15800807
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndromes.
Adès L; Itzykson R; Fenaux P
Lancet; 2014 Jun; 383(9936):2239-52. PubMed ID: 24656536
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutic agents for the treatment of myelodysplastic syndromes.
Cheson BD; Zwiebel JA; Dancey J; Murgo A
Semin Oncol; 2000 Oct; 27(5):560-77. PubMed ID: 11049023
[TBL] [Abstract][Full Text] [Related]
17. More is better: combination therapies for myelodysplastic syndromes.
Ornstein MC; Mukherjee S; Sekeres MA
Best Pract Res Clin Haematol; 2015 Mar; 28(1):22-31. PubMed ID: 25659727
[TBL] [Abstract][Full Text] [Related]
18. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias.
Karp JE
Curr Opin Oncol; 1998 Jan; 10(1):3-9. PubMed ID: 9466478
[TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic Syndromes: Diagnosis and Treatment.
Steensma DP
Mayo Clin Proc; 2015 Jul; 90(7):969-83. PubMed ID: 26141335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
